{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T10:43:16Z","timestamp":1784198596963,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Surgical Oncology"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1007\/bf02557364","type":"journal-article","created":{"date-parts":[[2007,2,7]],"date-time":"2007-02-07T17:53:58Z","timestamp":1170870838000},"page":"137-141","source":"Crossref","is-referenced-by-count":115,"title":["Frequency of nonsentinel lymph node metastasis in melanoma"],"prefix":"10.1007","volume":"9","author":[{"given":"Kelly M.","family":"McMasters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merrick I.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Dirk","family":"Noyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki","family":"Viar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia B.","family":"Cerrito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S.","family":"Reintgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Sunbelt Melanoma Trial Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02557364_CR1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3322\/canjclin.51.1.15","volume":"51","author":"RT Greenlee","year":"2001","unstructured":"Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001.CA Cancer J Clin 2001;51:15\u201336.","journal-title":"CA Cancer J Clin"},{"key":"BF02557364_CR2","first-page":"228","volume-title":"Cutaneous Melanoma","author":"DS Reintgen","year":"1998","unstructured":"Reintgen DS, Rapaport DP, Tanabe KK, Ross MI. Lymphatic mapping and sentinel lymphadenectomy. In: Balch CM, Houghton AN, Sober AJ, Soong SJ, eds.Cutaneous Melanoma. 3rd ed. St. Louis: Quality Medical Publishing, Inc., 1998:228.","edition":"3rd ed."},{"key":"BF02557364_CR3","unstructured":"Wrightson WR, Reintgen DS, Edwards MJ, et al. Morbidity of sentinel lymph node (SLN) biopsy for melanoma. Abstract presented at the Society of Surgical Oncology 54th Annual Symposium, March 15\u201318, 2001."},{"key":"BF02557364_CR4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1055-3207(18)30195-9","volume":"8","author":"A Brobeil","year":"1999","unstructured":"Brobeil A, Cruse CW, Messina JL, et al. Cost analysis of sentinel lymph node biopsy as an alternative to elective lymph node dissection in patients with malignant melanoma.Surg Oncol Clin North Am 1999;8:435\u201345.","journal-title":"Surg Oncol Clin North Am"},{"key":"BF02557364_CR5","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1200\/JCO.1999.17.3.976","volume":"17","author":"JE Gershenwald","year":"1999","unstructured":"Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients.J Clin Oncol 1999;17:976\u201383.","journal-title":"J Clin Oncol"},{"key":"BF02557364_CR6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF02303844","volume":"5","author":"E Joesph","year":"1998","unstructured":"Joesph E, Brobeil A, Glass F, et al. Results of complete lymph node dissection in 83 patients with positive sentinel nodes.Ann Surg Oncol 1998;5:119\u201325.","journal-title":"Ann Surg Oncol"},{"key":"BF02557364_CR7","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00000658-200102000-00015","volume":"233","author":"BM Clary","year":"2001","unstructured":"Clary BM, Brady MS, Lewis JL, Coit DG. Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence.Ann Surg 2001;233:250\u20138.","journal-title":"Ann Surg"},{"key":"BF02557364_CR8","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s10434-999-0144-y","volume":"6","author":"FF Haddad","year":"1999","unstructured":"Haddad FF, Stall A, Messina J, et al. The progression of melanoma nodal metastasis is dependent on tumor thickness of the primary lesion.Ann Surg Oncol 1999;6:144\u20139.","journal-title":"Ann Surg Oncol"},{"key":"BF02557364_CR9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s10434-001-0192-4","volume":"8","author":"KM McMasters","year":"2001","unstructured":"McMasters KM, Reintgen DS, Ross MI, et al. Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed?Ann Surg Oncol 2001;8:192\u20137.","journal-title":"Ann Surg Oncol"},{"key":"BF02557364_CR10","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s10434-999-0398-4","volume":"6","author":"JD Wagner","year":"1999","unstructured":"Wagner JD, Davidson D, Coleman JJ, et al. Lymph node tumor volumes in patients undergoing sentinel lymph node biopsy for cutaneous melanoma.Ann Surg Oncol 1999;6:398\u2013404.","journal-title":"Ann Surg Oncol"},{"key":"BF02557364_CR11","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","volume":"127","author":"DL Morton","year":"1992","unstructured":"Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma.Arch Surg 1992;127:392\u20139.","journal-title":"Arch Surg"},{"key":"BF02557364_CR12","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/00000658-199412000-00009","volume":"220","author":"D Reintgen","year":"1994","unstructured":"Reintgen D, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal metastases.Ann Surg 1994;220:759\u201367.","journal-title":"Ann Surg"},{"key":"BF02557364_CR13","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1001\/archsurg.1995.01430060092018","volume":"130","author":"DL Krag","year":"1995","unstructured":"Krag DL, Meijer SJ, Weaver DL, et al. Minimal-access surgery for staging of malignant melanoma.Arch Surg 1995;130:654\u20138.","journal-title":"Arch Surg"},{"key":"BF02557364_CR14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00008390-199508000-00008","volume":"5","author":"J Thompson","year":"1995","unstructured":"Thompson J, McCarthy W, Bosch C, et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes.Melanoma Res 1995;5:255\u201360.","journal-title":"Melanoma Res"},{"key":"BF02557364_CR15","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s10434-999-0442-4","volume":"6","author":"R Essner","year":"1999","unstructured":"Essner R, Conforti A, Kelley MC, et al. Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma.Ann Surg Oncol 1999;6:442\u20139.","journal-title":"Ann Surg Oncol"},{"key":"BF02557364_CR16","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/1097-0142(20000715)89:2<453::AID-CNCR34>3.0.CO;2-V","volume":"89","author":"JD Wagner","year":"2000","unstructured":"Wagner JD, Gordon MS, Chuang TY, et al. Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma.Cancer 2000;89:453\u201362.","journal-title":"Cancer"},{"key":"BF02557364_CR17","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/archsurg.1997.01430300108021","volume":"132","author":"SPL Leong","year":"1997","unstructured":"Leong SPL, Steinmetz I, Habib FA, et al. Optimal selective sentinel lymph node dissection in primary malignant melanoma.Arch Surg 1997;132:666\u201373.","journal-title":"Arch Surg"},{"key":"BF02557364_CR18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1067\/msy.2001.115830","volume":"130","author":"KM McMasters","year":"2001","unstructured":"McMasters KM, Wong SL, Edwards MJ, et al. Factors predicting the presence of sentinel lymph node metastasis in patients with melanoma.Surgery 2001;130:151\u20136.","journal-title":"Surgery"},{"key":"BF02557364_CR19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/archotol.126.3.313","volume":"126","author":"JD Wagner","year":"2000","unstructured":"Wagner JD, Park HM, Coleman JJ III, Love C, Hayes JT. Cervical sentinel lymph node biopsy for melanomas of the head and neck and upper thorax.Arch Otolaryngol Head Neck Surg 2000;126:313\u201321.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"BF02557364_CR20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/jsre.2001.6160","volume":"98","author":"WR Wrightson","year":"2001","unstructured":"Wrightson WR, Wong SL, Edwards MJ, et al. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of nonsentinel nodes following completion lymphadenectomy for melanoma.J Surg Res 2001;98:47\u201351.","journal-title":"J Surg Res"},{"key":"BF02557364_CR21","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1200\/JCO.1998.16.6.2253","volume":"16","author":"JE Gershenwald","year":"1998","unstructured":"Gershenwald JE, Colome MI, Lee JE, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma.J Clin Oncol 1998;16:2253\u201360.","journal-title":"J Clin Oncol"},{"key":"BF02557364_CR22","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0002-9610(98)00262-1","volume":"176","author":"BM Gogel","year":"1998","unstructured":"Gogel BM, Kuhn JA, Ferry KM, et al. Sentinel lymph node biopsy for melanoma.Am J Surg 1998;176:544\u20137.","journal-title":"Am J Surg"},{"key":"BF02557364_CR23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archsurg.134.4.381","volume":"134","author":"MA Gadd","year":"1999","unstructured":"Gadd MA, Cosimi AB, Yu J, et al. Outcome of patients with melanoma and histologically negative sentinel lymph nodes.Arch Surg 1999;134:381\u20137.","journal-title":"Arch Surg"},{"key":"BF02557364_CR24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00000658-199910000-00001","volume":"230","author":"DL Morton","year":"1999","unstructured":"Morton DL, Thompson JF, Essner R, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group.Ann Surg 1999; 230:453\u201363.","journal-title":"Ann Surg"},{"key":"BF02557364_CR25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00000658-199609000-00002","volume":"224","author":"CM Balch","year":"1996","unstructured":"Balch CM, Soong S-J, Bartolucci AA, et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger.Ann Surg 1996;224:255\u201366.","journal-title":"Ann Surg"},{"key":"BF02557364_CR26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10434-000-0087-9","volume":"7","author":"CM Balch","year":"2000","unstructured":"Balch CM, Soong S, Ross MI, et al. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial.Ann Surg Oncol 2000;7:87\u201397.","journal-title":"Ann Surg Oncol"},{"key":"BF02557364_CR27","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0140-6736(97)08260-3","volume":"351","author":"N Cascinelli","year":"1998","unstructured":"Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme.Lancet 1998;351:793\u20136.","journal-title":"Lancet"},{"key":"BF02557364_CR28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.1996.14.1.7","volume":"14","author":"JM Kirkwood","year":"1996","unstructured":"Kirkwood JM, Strawderman MH, Ernstoff MS, et al. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.J Clin Oncol 1996;14:7\u201317.","journal-title":"J Clin Oncol"},{"key":"BF02557364_CR29","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1200\/JCO.2000.18.12.2444","volume":"18","author":"JM Kirkwood","year":"2000","unstructured":"Kirkwood JM, Ibrahim J, Sondak V, et al. High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690\/S9111\/C9190.J Clin Oncol 2000;18:2444\u201358.","journal-title":"J Clin Oncol"},{"key":"BF02557364_CR30","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1200\/JCO.2001.19.9.2370","volume":"19","author":"JM Kirkwood","year":"2001","unstructured":"Kirkwood JM, Ibrahim JG, Sosman JA, et al. High dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH\/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694\/S9512\/C509801.J Clin Oncol 2001;19:2370\u201380.","journal-title":"J Clin Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02557364.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02557364\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02557364","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T22:14:34Z","timestamp":1558304074000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02557364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["BF02557364"],"URL":"https:\/\/doi.org\/10.1007\/bf02557364","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}